22 research outputs found

    Pulmonary flow profile and distensibility following acute pulmonary embolism

    Get PDF
    <p>Abstract</p> <p>Objective</p> <p>Proof of concept study evaluating CMR as screening tool for chronic thromboembolic pulmonary hypertension (CTEPH) in patients treated for acute pulmonary embolism (PE).</p> <p>Materials and methods</p> <p>Right and left ventricular function of 15 consecutive patients treated for PE and 10 consecutive patients in whom PE was excluded was estimated at baseline by cardiac CT and at 6 months follow-up by CMR. Additionally, during the follow-up visit, pulmonary artery (PA) hemodynamics were studied by CMR and the presence of pulmonary hypertension by echocardiography.</p> <p>Results</p> <p>CT measured right ventricular ejection fraction (RVEF) was lower in patients with PE compared to patients without PE at time of diagnosis (median 47%, interquartile range 39-53 vs. 55%, 52-58; p = 0.014). After 6 months follow up, the RVEF between patients treated for PE and patients without PE were not statistically significant different (55%, 52-60 versus 54%, 51-57; p = 0.57), as were distensibility index (0.18 Ā± 0.18 versus 0.25 Ā± 0.18, p = 0.20), mean velocity (14.1 Ā± 3.9 cm/s versus 14.0 Ā± 2.5 cm/s, p = 0.81), peak velocity (86.5 Ā± 22 cm/s versus 89.6 Ā± 13 cm/s, p = 0.43) and time to peak PA blood flow velocity (142 Ā± 49 ms versus 161 Ā± 29 ms, p = 0.14). One patient was diagnosed with CTEPH and CMR revealed poor right systolic function, decreased PA distensibility and flow velocity, and a systolic notch in the PA flow profile consistent with persistent PA obstruction.</p> <p>Conclusion</p> <p>In this small series, right ventricular performance and PA flow profiles of patients treated for 6 months after PE are equivalent to those parameters in normal patients.</p
    corecore